BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clurman BE, Roberts JM. Cell cycle and cancer. J Natl Cancer Inst. 1995;87:1499-1501. [PMID: 7563177 DOI: 10.1093/jnci/87.20.1499] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Møller MB. p27 in Cell Cycle Control and Cancer. Leukemia & Lymphoma 2009;39:19-27. [DOI: 10.3109/10428190009053535] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
2 López-Saiz CM, Suárez-Jiménez GM, Plascencia-Jatomea M, Burgos-Hernández A. Shrimp lipids: a source of cancer chemopreventive compounds. Mar Drugs 2013;11:3926-50. [PMID: 24135910 DOI: 10.3390/md11103926] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
3 Porter PL, Barlow WE, Yeh IT, Lin MG, Yuan XP, Donato E, Sledge GW, Shapiro CL, Ingle JN, Haskell CM, Albain KS, Roberts JM, Livingston RB, Hayes DF. p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst 2006;98:1723-31. [PMID: 17148774 DOI: 10.1093/jnci/djj467] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
4 Joo M, Kang YK, Kim MR, Lee HK, Jang JJ. Cyclin D1 overexpression in hepatocellular carcinoma. Liver. 2001;21:89-95. [PMID: 11318977 DOI: 10.1034/j.1600-0676.2001.021002089.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 2.8] [Reference Citation Analysis]
5 Donnellan R, Chetty R. Cyclin D1 and human neoplasia. Mol Pathol 1998;51:1-7. [PMID: 9624412 DOI: 10.1136/mp.51.1.1] [Cited by in Crossref: 222] [Cited by in F6Publishing: 200] [Article Influence: 9.3] [Reference Citation Analysis]
6 Saarilahti K, Kajanti M, Kouri M, Aaltonen L, Franssila K, Joensuu H. Cyclin A and Ki-67 expression as predictors for locoregional recurrence and outcome in laryngeal cancer patients treated with surgery and postoperative radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2003;57:986-95. [DOI: 10.1016/s0360-3016(03)00736-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
7 Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F. Cytometry of cyclin proteins. Cytometry 1996;25:1-13. [DOI: 10.1002/(sici)1097-0320(19960901)25:1<1::aid-cyto1>3.0.co;2-n] [Cited by in Crossref: 137] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
8 Daidone MG, Costa A, Silvestrini R. Cell proliferation markers in human solid tumors: Assessing their impact in clinical oncology. Cytometry: Part B. Elsevier; 2001. pp. 359-84. [DOI: 10.1016/s0091-679x(01)64022-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Morgan MB, Cowper SE. Expression of p-27 (kip1) in Nevi and Melanomas: . The American Journal of Dermatopathology 1999;21:121-4. [DOI: 10.1097/00000372-199904000-00002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
10 Peters J, Loud J, Dimond E, Jenkins J. Cancer Genetics Fundamentals: . Cancer Nursing 2001;24:446-61. [DOI: 10.1097/00002820-200112000-00005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
11 Brock CS, Bower M. Current perspectives in gliomas. Med Oncol 1997;14:103-20. [PMID: 9330270 DOI: 10.1007/BF02990955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
12 Chellappan SP, Giordano A, Fisher PB. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr Top Microbiol Immunol. 1998;227:57-103. [PMID: 9479826 DOI: 10.1007/978-3-642-71941-7_4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 33] [Article Influence: 0.9] [Reference Citation Analysis]
13 Yang C, Xiong W, Qiu Q, Tahiri H, Superstein R, Carret AS, Sapieha P, Hardy P. Anti-proliferative and anti-tumour effects of lymphocyte-derived microparticles are neither species- nor tumour-type specific. J Extracell Vesicles 2014;3. [PMID: 24834146 DOI: 10.3402/jev.v3.23034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
14 Yue H, Na YL, Feng XL, Ma SR, Song FL, Yang B. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer. World J Gastroenterol 2003; 9(2): 377-380 [PMID: 12532471 DOI: 10.3748/wjg.v9.i2.377] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
15 Milenković S, Marinkovic T, Jovanovic MB, Djuricic S, Berisavac II, Berisavac I. Cyclin D1 Immunoreactivity in Meningiomas. Cell Mol Neurobiol 2008;28:907-13. [DOI: 10.1007/s10571-008-9278-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
16 Hilleman MR. Overview of Viruses, Cancer, and Vaccines in Concept and in Reality. In: Schwab M, Rabes HM, Munk K, Hofschneider HP, editors. Genes and Environment in Cancer. Berlin: Springer Berlin Heidelberg; 1998. pp. 345-62. [DOI: 10.1007/978-3-642-46870-4_26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
17 Platz A, Sevigny P, Norberg T, Ring P, Lagerlöf B, Ringborg U. Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases. Br J Cancer 1996;74:936-41. [PMID: 8826861 DOI: 10.1038/bjc.1996.460] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
18 Brown MA. Tumor suppressor genes and human cancer. Adv Genet. 1997;36:45-135. [PMID: 9348653 DOI: 10.1016/s0065-2660(08)60307-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
19 So JB, Samarasinge K, Raju GC, Moochhala SM, Ti TK. Expression of cell-cycle regulators p27 and cyclin E correlates with survival in gastric carcino-ma patients. J Surg Res. 2000;94:56-60. [PMID: 11038303 DOI: 10.1006/jsre.2000.5998] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
20 Cordon-Cardo C, Prives C. At the crossroads of inflammation and tumorigenesis. J Exp Med. 1999;190:1367-1370. [PMID: 10562311 DOI: 10.1084/jem.190.10.1367] [Cited by in Crossref: 93] [Cited by in F6Publishing: 92] [Article Influence: 4.0] [Reference Citation Analysis]
21 Yue H, Jiang HY. Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: An immunohistochemical study. World J Gastroenterol 2005; 11(32): 5057-5060 [PMID: 16124066 DOI: 10.3748/wjg.v11.i32.5057] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
22 Shao JC, Wu JF, Wang DB, Qin R, Zhang H. Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance. World J Gastroenterol 2003; 9(3): 427-431 [PMID: 12632490 DOI: 10.3748/wjg.v9.i3.427] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
23 Kao CY, Tanimoto A, Arima N, Sasaguri Y, Padmanabhan R. Transactivation of the human cdc2 promoter by adenovirus E1A. E1A induces the expression and assembly of a heteromeric complex consisting of the CCAAT box binding factor, CBF/NF-Y, and a 110-kDa DNA-binding protein. J Biol Chem 1999;274:23043-51. [PMID: 10438472 DOI: 10.1074/jbc.274.33.23043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
24 Rho SB, Park YG, Park K, Lee SH, Lee JH. A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis. FEBS Lett 2006;580:4073-80. [PMID: 16828757 DOI: 10.1016/j.febslet.2006.06.047] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
25 Dzietczenia J, Wróbel T, Jaźwiec B, Mazur G, Butrym A, Kuliczkowski K. Expression of cyclin A and bone morphogenetic protein receptors and response to induction therapy in patients with acute leukemias. Leukemia & Lymphoma 2011;52:2336-41. [DOI: 10.3109/10428194.2011.597903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Lee SJ, Ha MJ, Lee J, Nguyen P, Choi YH, Pirnia F, Kang W, Wang X, Kim S, Trepel JB. Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 in Human Prostate Carcinoma Cells. Journal of Biological Chemistry 1998;273:10618-23. [DOI: 10.1074/jbc.273.17.10618] [Cited by in Crossref: 123] [Cited by in F6Publishing: 117] [Article Influence: 5.1] [Reference Citation Analysis]
27 Kawada M, Kuwahara A, Nishikiori T, Mizuno S, Uehara Y. NA22598, a Novel Antitumor Compound, Reduces Cyclin D1 Levels, Arrests Cell Cycle at G1 Phase, and Inhibits Anchorage-Independent Growth of Human Tumor Cells. Experimental Cell Research 1999;249:240-7. [DOI: 10.1006/excr.1999.4467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
28 Rosania GR, Chang Y. Targeting hyperproliferative disorders with cyclin dependent kinase inhibitors. Expert Opinion on Therapeutic Patents 2005;10:215-30. [DOI: 10.1517/13543776.10.2.215] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
29 Salesiotis AN, Cullen KJ. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging: . Current Opinion in Oncology 2000;12:229-39. [DOI: 10.1097/00001622-200005000-00008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
30 Yue H, Yu JP, Cao YH, Zhao X. Expression of p57kip2 and p27kip1 proteins and its relationship with clinicopathology in human pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2003; 11(3): 318-320 [DOI: 10.11569/wcjd.v11.i3.318] [Reference Citation Analysis]
31 Ahlin C, Gruhne B, Holmqvist M, Zetterberg A, Fjällskog M. Aberrant expression of cyclin E in low-risk node negative breast cancer. Acta Oncologica 2009;47:1539-45. [DOI: 10.1080/02841860701856581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med. 1997;3:222-225. [PMID: 9018243 DOI: 10.1038/nm0297-222] [Cited by in Crossref: 621] [Cited by in F6Publishing: 569] [Article Influence: 24.8] [Reference Citation Analysis]
33 Hurteau JA, Allison BM, Brutkiewicz SA, Goebl MG, Heilman DK, Bigsby RM, Harrington MA. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer. Gynecol Oncol 2001;83:292-8. [PMID: 11606087 DOI: 10.1006/gyno.2001.6376] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
34 Jung K, Park K, Bullerman LB. Anticancer Effects of Leek Kimchi on Human Cancer Cells. JFN 2002;7:250-4. [DOI: 10.3746/jfn.2002.7.3.250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
35 Mineta H, Miura K, Suzuki I, Takebayashi S, Amano H, Araki K, Harada H, Ichimura K, Wennerberg JP, Dictor MR. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer 1999;85:1011-7. [PMID: 10091782 DOI: 10.1002/(sici)1097-0142(19990301)85:5<1011::aid-cncr1>3.0.co;2-0] [Cited by in Crossref: 69] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
36 Guevara P, Escobar-arriaga E, Saavedra-perez D, Martinez-rumayor A, Flores-estrada D, Rembao D, Calderon A, Sotelo J, Arrieta O. Angiogenesis and expression of estrogen and progesterone receptors as predictive factors for recurrence of meningioma. J Neurooncol 2010;98:379-84. [DOI: 10.1007/s11060-009-0086-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
37 Warnakulasuriya KAAS, Johnson NW. Importance of Proliferation Markers in Oral Pathology. In: Seifert G, editor. Oral Pathology. Berlin: Springer Berlin Heidelberg; 1996. pp. 147-77. [DOI: 10.1007/978-3-642-80169-3_5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
38 Lin Y, Tai S, Huang Y, Chang C, Juan W, Chao L, Wen M, Hung Y, Lee E. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas: Application of Flow Cytometry. Cytometry 2015;88:312-9. [DOI: 10.1002/cyto.b.21202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
39 Orlow I, Drobnjak M, Zhang ZF, Lewis J, Woodruff JM, Brennan MF, Cordon-Cardo C. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival. J Natl Cancer Inst. 1999;91:73-79. [PMID: 9890173 DOI: 10.1093/jnci/91.1.73] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 2.2] [Reference Citation Analysis]
40 Leivonen M, Nordling S, Lundin J, von Boguslawski K, Haglund C. p27 expression correlates with short-term, but not with long-term prognosis in breast cancer. Breast Cancer Res Treat 2001;67:15-22. [PMID: 11518462 DOI: 10.1023/a:1010623326118] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
41 Antonescu CR, Leung DH, Dudas M, Ladanyi M, Brennan M, Woodruff JM, Cordon-Cardo C. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications. Am J Pathol 2000;156:977-83. [PMID: 10702413 DOI: 10.1016/S0002-9440(10)64965-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
42 Duan H, Tsvetkov LM, Liu Y, Song Y, Swaroop M, Wen R, Kung HF, Zhang H, Sun Y. Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: association with inhibition of p27 accumulation. Mol Carcinog 2001;30:37-46. [PMID: 11255262 DOI: 10.1002/1098-2744(200101)30:1<37::aid-mc1011>3.0.co;2-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
43 Kostić I, Roy R. Organ-specific cell division abnormalities caused by mutation in a general cell cycle regulator in C. elegans. Development 2002;129:2155-65. [DOI: 10.1242/dev.129.9.2155] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
44 Wang A, Yoshimi N, Ino N, Tanaka T, Mori H. Overexpression of cyclin B1 in human colorectal cancers. J Cancer Res Clin Oncol 1997;123:124-7. [DOI: 10.1007/bf01269891] [Cited by in Crossref: 75] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
45 Hurteau JA, Allison B, Sutton GP, Moore DH, Look KY, Hurd W, Bigsby RM. Transforming growth factor-? differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1. Cancer 1999;85:1810-5. [DOI: 10.1002/(sici)1097-0142(19990415)85:8<1810::aid-cncr22>3.0.co;2-e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Grem JL. Recent insights into the molecular basis of intrinsic resistance of colorectal cancer: new challenges for systemic therapeutic approaches. Cancer Treat Res 1998;98:293-338. [PMID: 10326673 DOI: 10.1007/978-1-4615-4977-2_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.0] [Reference Citation Analysis]
47 Kawada M, Uehara Y, Mizuno S, Yamori T, Tsuruo T. Up-regulation of p27Kip1 correlates inversely with anchorage-independent growth of human cancer cell lines. Jpn J Cancer Res 1998;89:110-5. [PMID: 9548436 DOI: 10.1111/j.1349-7006.1998.tb00537.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
48 Hurteau JA, Brutkiewicz SA, Wang Q, Allison BM, Goebl MG, Harrington MA. Overexpression of a stabilized mutant form of the cyclin-dependent kinase inhibitor p27(Kip1) inhibits cell growth. Gynecol Oncol. 2002;86:19-23. [PMID: 12079294 DOI: 10.1006/gyno.2002.6657] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
49 Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, Scheithauer BW. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999;154:313-23. [PMID: 10027389 DOI: 10.1016/S0002-9440(10)65277-7] [Cited by in Crossref: 387] [Cited by in F6Publishing: 123] [Article Influence: 16.8] [Reference Citation Analysis]
50 Harman AE, Voigt JM, Frame SR, Bogdanffy MS. Mitogenic responses of rat nasal epithelium to hexamethylphosphoramide inhalation exposure. Mutat Res 1997;380:155-65. [PMID: 9385396 DOI: 10.1016/s0027-5107(97)00133-4] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
51 Del Pizzo JJ, Borkowski A, Jacobs SC, Kyprianou N. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol 1999;155:1129-36. [PMID: 10514396 DOI: 10.1016/S0002-9440(10)65216-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
52 Chetty R, Subramoney T, Singh JP. Retinoblastoma and p53 protein expression in sporadic colorectal cancers. Eur J Surg Oncol 1998;24:436-9. [PMID: 9800976 DOI: 10.1016/s0748-7983(98)92434-9] [Reference Citation Analysis]
53 Span PN, de Mulder PH, Sweep FC. Re: p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst 2007;99:738. [PMID: 17470742 DOI: 10.1093/jnci/djk163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Choi YJ, Choi YL, Cho EY, Shin YK, Sung KW, Hwang YK, Lee SJ, Kong G, Lee JE, Kim JS, Kim JH, Yang JH, Nam SJ. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients. Breast Cancer Res Treat 2009;113:83-93. [PMID: 18228133 DOI: 10.1007/s10549-008-9909-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
55 Tafrihi M, Imran M, Tufail T, Gondal TA, Caruso G, Sharma S, Sharma R, Atanassova M, Atanassov L, Valere Tsouh Fokou P, Pezzani R. The Wonderful Activities of the Genus Mentha: Not Only Antioxidant Properties. Molecules 2021;26:1118. [PMID: 33672486 DOI: 10.3390/molecules26041118] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
56 Sabah M, Cummins R, Leader M, Kay E. Aberrant expression of the Rb pathway proteins in soft tissue sarcomas. Appl Immunohistochem Mol Morphol 2006;14:397-403. [PMID: 17122635 DOI: 10.1097/01.pai.0000190176.06200.68] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
57 Sabah M, Cummins R, Leader M, Kay E. Immunoreactivity of p53, Mdm2, p21WAF1/CIP1, Bcl-2, and Bax in Soft Tissue Sarcomas: Correlation With Histologic Grade. Applied Immunohistochemistry & Molecular Morphology 2007;15:64-9. [DOI: 10.1097/01.pai.0000201809.43554.ed] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
58 Ravandi-kashani F, O’brien S, Manshouri T, Lerner S, Sim S, Dodd K, Kantarjian H, Freireich E, Keating M, Albitar M. Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia. Leukemia Research 2000;24:469-74. [DOI: 10.1016/s0145-2126(00)00008-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
59 Gerber M. Oxidative stress, antioxidants and cancer. Handbook of Oxidants and Antioxidants in Exercise. Elsevier; 2000. pp. 927-49. [DOI: 10.1016/b978-044482650-3/50031-6] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
60 Gomes A, Choudhury SR, Saha A, Mishra R, Giri B, Biswas A, Debnath A, Gomes A. A heat stable protein toxin (drCT-I) from the Indian Viper (Daboia russelli russelli) venom having antiproliferative, cytotoxic and apoptotic activities. Toxicon 2007;49:46-56. [DOI: 10.1016/j.toxicon.2006.09.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
61 Hickman JA. Apoptosis and chemotherapy resistance. Eur J Cancer 1996;32A:921-6. [PMID: 8763333 DOI: 10.1016/0959-8049(96)00080-9] [Cited by in Crossref: 117] [Cited by in F6Publishing: 107] [Article Influence: 4.5] [Reference Citation Analysis]
62 Conrad N, Leis P, Orengo I, Medrano EE, Hayes TG, Baer S, Rosen T. Multiple Primary Melanoma: . Dermatologic Surgery 1999;25:576-81. [DOI: 10.1046/j.1524-4725.1999.98050.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
63 Tao J, Zhi X, Tian Y, Li Z, Zhu Y, Wang W, Xie K, Tang J, Zhang X, Wang L, Xu Z. CEP55 contributes to human gastric carcinoma by regulating cell proliferation. Tumour Biol. 2014;35:4389-4399. [PMID: 24390615 DOI: 10.1007/s13277-013-1578-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
64 Sawasaki T, Shigemasa K, Shiroyama Y, Kusuda T, Fujii T, Parmley TH, O'brien TJ, Ohama K. Cyclin E mRNA Overexpression in Epithelial Ovarian Cancers: Inverse Correlation with p53 Protein Accumulation. Journal of the Society for Gynecologic Investigation 2016;8:179-85. [DOI: 10.1177/107155760100800310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Chen X, Liu MX, Yan GY. RWRMDA: predicting novel human microRNA-disease associations. Mol Biosyst 2012;8:2792-8. [PMID: 22875290 DOI: 10.1039/c2mb25180a] [Cited by in Crossref: 272] [Cited by in F6Publishing: 225] [Article Influence: 30.2] [Reference Citation Analysis]
66 Sabah M, Cummins R, Leader M, Kay E. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications. Human Pathology 2006;37:648-55. [DOI: 10.1016/j.humpath.2006.01.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]